NCT07224139 · ACTIVE NOT RECRUITING
Sex-specific Risk Factors and Trajectories of Blood Biomarkers for Alzheimer's Disease and Related Dementias
This study looks at blood tests that may help predict or detect Alzheimer's and related dementias. Researchers will track how these blood markers change over time and whether they work differently in women and men. It uses stored, de-identified samples and data from an earlier aspirin trial. No new treatment is being tested. The phase is not specified.
Eligibility criteria
Inclusion Criteria: We will use de-identified data and biospecimens originally collected for a large binational NIA-funded ASPirin in Reducing Events in the Elderly (ASPREE) randomized clinical trial and ongoing observational follow-up (U19 AG062682) for analysis. Exclusion Criteria: None
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2025-11-04